Looking for PHA3032 - Neuro and endocrine pharmacology - S2 2026 test answers and solutions? Browse our comprehensive collection of verified answers for PHA3032 - Neuro and endocrine pharmacology - S2 2026 at learning.monash.edu.
Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!
Which one of the following drugs is MOST commonly used as a therapy for Alzheimer’s disease, due to its favourable pharmacokinetic and pharmacodynamic profile?
The following is a cause/relationship question, which includes two statements - an assertion and a reason.
You must establish whether each individual statement of the pair is true or false, and then determine whether there is a relationship between the two, ie. does the reason (the second statement) provide an explanation for the assertion (first statement)?
Under physiological conditions, intracellular levels of adenosine are kept low
BECAUSE
Adenosine metabolism is tightly regulated by HIF-1α under physiological conditions
Which one of the following statements about drugs used for the treatment of epilepsy is CORRECT?
Which one of the following statements relating to cholinesterase inhibitors used for treating Alzheimer's disease is CORRECT?
George presented to the emergency department with neurological symptoms including visual disturbances and numbness in the arms and hands. The neurologist suspects multiple sclerosis (MS) and orders some diagnostic tests to confirm.
Which one of the following would NOT be utilised for an MS diagnosis?
Patient G has experienced a suspected stroke and is taken to the emergency department.
Within 3 hours of the symptoms starting, scans confirm an ischaemic stroke, where a clot is blocking a large cerebral artery.
Which one of the following is Patient G MOST LIKELY to be treated with first?
Which one of the following is TRUE of amyotrophic lateral sclerosis (ALS)?
Secondary progressive multiple sclerosis (MS):
Cladribine has recently been approved as a treatment for multiple sclerosis. Which one of the following statements is CORRECT?
Cladribine:
D2 receptor agonists: